CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection

Journal of Leukocyte Biology

Volumn 100, Issue 5, 2016, Pages 1125-1134

  Parkunan, Salai Madhumathi ^a   Randall, C Blake ^a   Astley, Roger A ^a   Furtado, Glaucia C ^b   Lira, Sergio A ^b   Callegan, Michelle C ^a,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Bacillus; Chemokine; Cytokine; Eye endophthalmitis; Mouse

Indexed keywords

CXCL1 CHEMOKINE; CYTOKINE ANTIBODY; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; AUTACOID; CXCL1 PROTEIN, MOUSE; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACILLUS CEREUS INFECTION; CLINICAL OUTCOME; CONTROLLED STUDY; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VISUAL SYSTEM FUNCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BACILLUS CEREUS; BACTERIAL EYE INFECTION; BACTERIAL LOAD; C57BL MOUSE; DEFICIENCY; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; ISOLATION AND PURIFICATION; KNOCKOUT MOUSE; MICROBIOLOGY; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY; RETINA;

ANIMALS; ANTIBODIES, MONOCLONAL; BACILLUS CEREUS; BACTERIAL LOAD; CHEMOKINE CXCL1; CHEMOTAXIS, LEUKOCYTE; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PEROXIDASE; RETINA;

EID: 84994071535     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.3A0416-173R     Document Type: Article

References (87)

1. Streilein, J. W. (2003) Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 3, 879-889.
2. Uchino, Y., Iriyama, N., Matsumoto, K., Hirabayashi, Y., Miura, K., Kurita, D., Kobayashi, Y., Yagi, M., Kodaira, H., Hojo, A., Kobayashi, S., Hatta, Y., Takeuchi, J. (2012) A case series of Bacillus cereus septicemia in patients with hematological disease. Intern. Med. 51, 2733-2738.
3. Arnaout, M. K., Tamburro, R. F., Bodner, S. M., Sandlund, J. T., Rivera, G. K., Pui, C. H., Ribeiro, R. C. (1999) Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia. J. Pediatr. Hematol. Oncol. 21, 431-435.
4. Frankard, J., Li, R., Taccone, F., Struelens, M. J., Jacobs, F., Kentos, A. (2004) Bacillus cereus pneumonia in a patient with acute lymphoblastic leukemia. Eur. J. Clin. Microbiol. Infect. Dis. 23, 725-728.
5. Berner, R., Heinen, F., Pelz, K., van Velthoven, V., Sauer, M., Korinthenberg, R. (1997) Ventricular shunt infection and meningitis due to Bacillus cereus. Neuropediatrics 28, 333-334.
6. Tuazon, C. U., Murray, H. W., Levy, C., Solny, M. N., Curtin, J. A., Sheagren, J. N. (1979) Serious infections from Bacillus sp. JAMA 241, 1137-1140.
7. Drobniewski, F. A. (1993) Bacillus cereus and related species. Clin. Microbiol. Rev. 6, 324-338.
8. Ihde, D. C., Armstrong, D. (1973) Clinical spectrum of infection due to Bacillus species. Am. J. Med. 55, 839-845.
9. Colpin, G. G. D., Guiot, H. F. L., Simonis, R. F. A., Zwaan, F. E. (1981) Bacillus cereus meningitis in a patient under gnotobiotic care. Lancet 2, 694-695.
10. Funada, H., Uotani, C., Machi, T., Matsuda, T., Nonomura, A. (1988) Bacillus cereus bacteremia in an adult with acute leukemia. Jpn. J. Clin. Oncol. 18, 69-74.
11. Jenson, H. B., Levy, S. R., Duncan, C., Mcintosh, S. (1989) Treatment of multiple brain abscesses caused by Bacillus cereus. Pediatr. Infect. Dis. J. 8, 795-798.
12. Yoshida, H., Moriyama, Y., Tatekawa, T., Tominaga, N., Teshima, H., Hiraoka, A., Masaoka, T., Yoshinaga, T. (1993) Two cases of acute myelogenous leukemia with Bacillus cereus bacteremia resulting in fatal intracranial hemorrhage [in Japanese]. Rinsho Ketsueki 34, 1568-1572.
13. Gaur, A. H., Patrick, C. C., McCullers, J. A., Flynn, P. M., Pearson, T. A., Razzouk, B. I., Thompson, S. J., Shenep, J. L. (2001) Bacillus cereus bacteremia and meningitis in immunocompromised children. Clin. Infect. Dis. 32, 1456-1462.
14. Marley, E. F., Saini, N. K., Venkatraman, C., Orenstein, J. M. (1995) Fatal Bacillus cereus meningoencephalitis in an adult with acute myelogenous leukemia. South. Med. J. 88, 969-972.
15. Steen, M. K., Bruno-Murtha, L. A., Chaux, G., Lazar, H., Bernard, S., Sulis, C. (1992) Bacillus cereus endocarditis: report of a case and review. Clin. Infect. Dis. 14, 945-946.
16. Centers for Disease Control and Prevention (CDC). (2011) Notes from the field: contamination of alcohol prep pads with Bacillus cereus group and Bacillus species-Colorado, 2010. MMWR Morb. Mortal. Wkly. Rep. 60, 347.
17. Dolan, S. A., Littlehorn, C., Glodé, M. P., Dowell, E., Xavier, K., Nyquist, A. C., Todd, J. K. (2012) Association of Bacillus cereus infection with contaminated alcohol prep pads. Infect. Control Hosp. Epidemiol. 33, 666-671.
18. Sasahara, T., Hayashi, S., Morisawa, Y., Sakihama, T., Yoshimura, A., Hirai, Y. (2011) Bacillus cereus bacteremia outbreak due to contaminated hospital linens. Eur. J. Clin. Microbiol. Infect. Dis. 30, 219-226.
19. Kato, K., Matsumura, Y., Yamamoto, M., Nagao, M., Ito, Y., Takakura, S., Ichiyama, S. (2014) Seasonal trend and clinical presentation of Bacillus cereus bloodstream infection: association with summer and indwelling catheter. Eur. J. Clin. Microbiol. Infect. Dis. 33, 1371-1379.
20. Turabelidze, G., Gee, J. E., Hoffmaster, A. R., Manian, F., Butler, C., Byrd, D., Schildknecht, S., Hauser, L. C., Duncan, M., Ferrett, R., Evans, D., Talley, C. (2013) Contaminated ventilator air flow sensor linked to Bacillus cereus colonization of newborns. Emerg. Infect. Dis. 19, 781-783.
21. David, D. B., Kirkby, G. R., Noble, B. A. (1994) Bacillus cereus endophthalmitis. Br. J. Ophthalmol. 78, 577-580.
22. Davey, R. T., Jr., Tauber, W. B. (1987) Posttraumatic endophthalmitis: the emerging role of Bacillus cereus infection. Rev. Infect. Dis. 9, 110-123.
23. Chan, W. M., Liu, D. T., Chan, C. K., Chong, K. K., Lam, D. S. (2003) Infective endophthalmitis caused by Bacillus cereus after cataract extraction surgery. Clin. Infect. Dis. 37, e31-e34.
24. Roy, M., Chen, J. C., Miller, M., Boyaner, D., Kasner, O., Edelstein, E. (1997) Epidemic Bacillus endophthalmitis after cataract surgery I: acute presentation and outcome. Ophthalmology 104, 1768-1772.
25. Chen, J. C., Roy, M. (2000) Epidemic Bacillus endophthalmitis after cataract surgery II: chronic and recurrent presentation and outcome. Ophthalmology 107, 1038-1041.
26. Cowan, C. L., Jr., Madden, W. M., Hatem, G. F., Merritt, J. C. (1987) Endogenous Bacillus cereus panophthalmitis. Ann. Ophthalmol. 19, 65-68.
27. Masi, R. J. (1978) Endogenous endophthalmitis associated with Bacillus cereus bacteremia in a cocaine addict. Ann. Ophthalmol. 10, 1367-1370.
28. Bouza, E., Grant, S., Jordan, C., Yook, R. H., Sulit, H. L. (1979) Bacillus cereus endogenous panophthalmitis. Arch. Ophthalmol. 97, 498-499.
29. O’Day, D. M., Smith, R. S., Gregg, C. R., Turnbull, P. C., Head, W. S., Ives, J. A., Ho, P. C. (1981) The problem of bacillus species infection with special emphasis on the virulence of Bacillus cereus. Ophthalmology 88, 833-838.
30. Ramadan, R. T., Ramirez, R., Novosad, B. D., Callegan, M. C. (2006) Acute inflammation and loss of retinal architecture and function during experimental Bacillus endophthalmitis. Curr. Eye Res. 31, 955-965.
31. Ravindranath, R. M., Mondino, B. J., Adamu, S. A., Pitchekian-Halabi, H., Hasan, S. A., Glasgow, B. J. (1995) Immunopathologic features of Staphylococcus aureus endophthalmitis in the rat. Invest. Ophthalmol. Vis. Sci. 36, 2482-2491.
32. Giese, M. J., Rayner, S. A., Fardin, B., Sumner, H. L., Rozengurt, N., Mondino, B. J., Gordon, L. K. (2003) Mitigation of neutrophil infiltration in a rat model of early Staphylococcus aureus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 44, 3077-3082.
33. Novosad, B. D., Astley, R. A., Callegan, M. C. (2011) Role of Toll-like receptor (TLR) 2 in experimental Bacillus cereus endophthalmitis. PLoS One 6, e28619.
34. Parkunan, S. M., Astley, R., Callegan, M. C. (2014) Role of TLR5 and flagella in Bacillus intraocular infection. PLoS One 9, e100543.
35. Parkunan, S. M., Randall, C. B., Coburn, P. S., Astley, R. A., Staats, R. L., Callegan, M. C. (2015) Unexpected roles for Toll-like receptor 4 and TRIF in intraocular infection with gram-positive bacteria. Infect. Immun. 83, 3926-3936.
36. Kumar, A., Singh, C. N., Glybina, I. V., Mahmoud, T. H., Yu, F. S. (2010) Toll-like receptor 2 ligand-induced protection against bacterial endophthalmitis. J. Infect. Dis. 201, 255-263.
37. Petropoulos, I. K., Vantzou, C. V., Lamari, F. N., Karamanos, N. K., Anastassiou, E. D., Pharmakakis, N. M. (2006) Expression of TNF-a, IL-1b, and IFN-g in Staphylococcus epidermidis slime-positive experimental endophthalmitis is closely related to clinical inflammatory scores. Graefes Arch. Clin. Exp. Ophthalmol. 244, 1322-1328.
38. Giese, M. J., Sumner, H. L., Berliner, J. A., Mondino, B. J. (1998) Cytokine expression in a rat model of Staphylococcus aureus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 39, 2785-2790.
39. Ramadan, R. T., Moyer, A. L., Callegan, M. C. (2008) A role for tumor necrosis factor-alpha in experimental Bacillus cereus endophthalmitis pathogenesis. Invest. Ophthalmol. Vis. Sci. 49, 4482-4489.
40. Boisvert, W. A., Rose, D. M., Johnson, K. A., Fuentes, M. E., Lira, S. A., Curtiss, L. K., Terkeltaub, R. A. (2006) Up-regulated expression of the CXCR2 ligand KC/GRO-a in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am. J. Pathol. 168, 1385-1395.
41. Hunt, J. J., Wang, J. T., Callegan, M. C. (2011) Contribution of mucoviscosity-associated gene A (magA) to virulence in experimental Klebsiella pneumoniae endophthalmitis. Invest. Ophthalmol. Vis. Sci. 52, 6860-6866
42. West, D. M., Del Rosso, C. R., Yin, X. T., Stuart, P. M. (2014) CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis. J. Immunol. 192, 1762-1767.
43. Callegan, M. C., Engelbert, M., Parke, D. W, II, Jett, B. D., Gilmore, M. S. (2002) Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin. Microbiol. Rev. 15, 111-124.
44. Callegan, M. C., Kane, S. T., Cochran, D. C., Gilmore, M. S. (2002) Molecular mechanisms of Bacillus endophthalmitis pathogenesis. DNA Cell Biol. 21, 367-373.
45. Wiskur, B. J., Robinson, M. L., Farrand, A. J., Novosad, B. D., Callegan, M. C. (2008) Toward improving therapeutic regimens for Bacillus endophthalmitis. Invest. Ophthalmol. Vis. Sci. 49, 1480-1487.
46. Callegan, M. C., Novosad, B. D., Ramadan, R. T., Wiskur, B., Moyer, A. L. (2009) Rate of bacterial eradication by ophthalmic solutions of fourthgeneration fluoroquinolones. Adv. Ther. 26, 447-454.
47. Benz, M. S., Scott, I. U., Flynn, H. W., Jr., Unonius, N., Miller, D. (2004) Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases. Am. J. Ophthalmol. 137, 38-42.
48. Recchia, F. M., Busbee, B. G., Pearlman, R. B., Carvalho-Recchia, C. A., Ho, A. C. (2005) Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch. Ophthalmol. 123, 341-346.
49. Callegan, M. C., Cochran, D. C., Kane, S. T., Ramadan, R. T., Chodosh, J., McLean, C., Stroman, D. W. (2006) Virulence factor profiles and antimicrobial susceptibilities of ocular Bacillus isolates. Curr. Eye Res. 31, 693-702.
50. Hariprasad, S. M., Mieler, W. F., Holz, E. R. (2003) Vitreous and aqueous penetration of orally administered gatifloxacin in humans. Arch. Ophthalmol. 121, 345-350.
51. Das, T., Jalali, S., Gothwal, V. K., Sharma, S., Naduvilath, T. J. (1999) Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br. J. Ophthalmol. 83, 1050-1055.
52. Gan, I. M., Ugahary, L. C., van Dissel, J. T., Feron, E., Peperkamp, E., Veckeneer, M., Mulder, P. G., Platenkamp, G. J., van Meurs, J. C. (2005) Intravitreal dexamethasone as adjuvant in the treatment of postoperative endophthalmitis: a prospective randomized trial. Graefes Arch. Clin. Exp. Ophthalmol. 243, 1200-1205.
53. Shah, G. K., Stein, J. D., Sharma, S., Sivalingam, A., Benson, W. E., Regillo, C. D., Brown, G. C., Tasman, W. (2000) Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 107, 486-489.
54. Meredith, T. A., Aguilar, H. E., Drews, C., Sawant, A., Gardner, S., Wilson, L. A., Grossniklaus, H. E. (1996) Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans. Am. Ophthalmol. Soc. 94, 241-252, discussion 252-257.
55. Liu, S. M., Way, T., Rodrigues, M., Steidl, S. M. (2000) Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Arch. Ophthalmol. 118, 803-806.
56. Pollack, J. S., Beecher, D. J., Pulido, J. S., Lee Wong, A. C. (2004) Failure of intravitreal dexamethasone to diminish inflammation or retinal toxicity in an experimental model of Bacillus cereus endophthalmitis. Curr. Eye Res. 29, 253-259.
57. Kochan, T. J., Blair, J., Kumar, A. (2011) Modulation of Toll-like receptor signaling in microglia by Tlr2, And Tlr4 ligands and their relevance to bacterial endophthalmitis. Invest. Ophthalmol. Vis. Sci. 52, 2958.
58. Hunt, J. J., Astley, R., Wheatley, N., Wang, J. T., Callegan, M. C. (2014) TLR4 contributes to the host response to Klebsiella intraocular infection. Curr. Eye Res. 39, 790-802.
59. Gregory-Ksander, M.S., Crane, M., Vincent W. J., TLR2, but not NOD2, is required for clearance of bacteria during S. aureus induced endophthalmitis. Invest. Ophthalmol. Vis. Sci. 52, 5864.
60. Kishimoto, T. (2006) Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res. Ther. 8, S2.
61. Kishimoto, T. (2005) IL-6: from laboratory to bedside. Clin. Rev. Allergy Immunol. 28, 177-186.
62. Mima, T., Nishimoto, N. (2009) Clinical value of blocking IL-6 receptor. Curr. Opin. Rheumatol. 21, 224-230.
63. Murakami, M., Nishimoto, N. (2011) The value of blocking IL-6 outside of rheumatoid arthritis: current perspective. Curr. Opin. Rheumatol. 23, 273-277.
64. Nishimoto, N., Kanakura, Y., Aozasa, K., Johkoh, T., Nakamura, M., Nakano, S., Nakano, N., Ikeda, Y., Sasaki, T., Nishioka, K., Hara, M., Taguchi, H., Kimura, Y., Kato, Y., Asaoku, H., Kumagai, S., Kodama, F., Nakahara, H., Hagihara, K., Yoshizaki, K., Kishimoto, T. (2005) Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106, 2627-2632.
65. Nishimoto, N., Kishimoto, T. (2006) Interleukin 6: from bench to bedside. Nat. Clin. Pract. Rheumatol. 2, 619-626.
66. Rossi, J. F., Lu, Z. Y., Jourdan, M., Klein, B. (2015) Interleukin-6 as a therapeutic target. Clin. Cancer Res. 21, 1248-1257.
67. Yoshimura, T., Sonoda, K.-H., Ohguro, N., Ohsugi, Y., Ishibashi, T., Cua, D. J., Kobayashi, T., Yoshida, H., Yoshimura, A. (2009) Involvement of Th17 cells and the effect of anti-IL-6 therapy in autoimmune uveitis. Rheumatology (Oxford) 48, 347-354.
68. Thomson, A. W. (1994) Cytokines and their receptors as potential therapeutic targets. In: The Cytokine Handbook, 2nd ed.., Elsevier, Maryland Heights, MO, USA, 525-566.
69. Lira, S. A., Zalamea, P., Heinrich, J. N., Fuentes, M. E., Carrasco, D., Lewin, A. C., Barton, D. S., Durham, S., Bravo, R. (1994) Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J. Exp. Med. 180, 2039-2048.
70. Baggiolini, M., Walz, A., Kunkel, S. L. (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest. 84, 1045-1049.
71. Rollins, B. J. (1997) Chemokines. Blood 90, 909-928.
72. Bacon, K. B., Oppenheim, J. J. (1998) Chemokines in disease models and pathogenesis. Cytokine Growth Factor Rev. 9, 167-173.
73. Wang, D., Wang, H., Brown, J., Daikoku, T., Ning, W., Shi, Q., Richmond, A., Strieter, R., Dey, S. K., DuBois, R. N. (2006) CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer. J. Exp. Med. 203, 941-951.
74. Mehrad, B., Wiekowski, M., Morrison, B. E., Chen, S.-C., Coronel, E. C., Manfra, D. J., Lira, S. A. (2002) Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. Am. J. Respir. Crit. Care Med. 166, 1263-1268.
75. Frevert, C. W., Huang, S., Danaee, H., Paulauskis, J. D., Kobzik, L. (1995) Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation. J. Immunol. 154, 335-344.
76. Bozic, C. R., Kolakowski, L. F., Jr., Gerard, N. P., Garcia-Rodriguez, C., von Uexkull-Guldenband, C., Conklyn, M. J., Breslow, R., Showell, H. J., Gerard, C. (1995) Expression and biologic characterization of the murine chemokine KC. J. Immunol. 154, 6048-6057.
77. Cai, S., Batra, S., Lira, S. A., Kolls, J. K., Jeyaseelan, S. (2010) CXCL1 regulates pulmonary host defense to Klebsiella Infection via CXCL2, CXCL5, NF-kappaB, and MAPKs. J. Immunol. 185, 6214-6225.
78. Shea-Donohue, T., Thomas, K., Cody, M. J., Aiping Zhao, Detolla, L. J., Kopydlowski, K. M., Fukata, M., Lira, S. A., Vogel, S. N. (2008) Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-a), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun. 14, 117-124.
79. Chintakuntlawar, A. V., Chodosh, J. (2009) Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. J. Interferon Cytokine Res. 29, 657-666.
80. Lo, H. M., Lai, T. H., Li, C. H., Wu, W. B. (2014) TNF-a induces CXCL1 chemokine expression and release in human vascular endothelial cells in vitro via two distinct signaling pathways. Acta Pharmacol. Sin. 35, 339-350.
81. Hao, Q., Wang, L., Tang, H. (2009) Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. Am. J. Physiol. Cell Physiol. 296, C821-C827.
82. Shieh, J. M., Tsai, Y. J., Tsou, C. J., Wu, W. B. (2014) CXCL1 regulation in human pulmonary epithelial cells by tumor necrosis factor. Cell. Physiol. Biochem. 34, 1373-1384.
83. Anisowicz, A., Messineo, M., Lee, S. W., Sager, R. (1991) An NF-kappa Blike transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J. Immunol. 147, 520-527.
84. Tessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., McColl, S. R. (1997) Chemokine networks in vivo: involvement of C-X-C and C-C chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J. Immunol. 159, 3595-3602.
85. Vieira, S. M., Lemos, H. P., Grespan, R., Napimoga, M. H., Dal-Secco, D., Freitas, A., Cunha, T. M., Verri, W. A., Jr., Souza-Junior, D. A., Jamur, M. C., Fernandes, K. S., Oliver, C., Silva, J. S., Teixeira, M. M., Cunha, F. Q. (2009) A crucial role for TNF-a in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/ CXCL1 and LIX/CXCL5. Br. J. Pharmacol. 158, 779-789.
86. Souza, D. G., Bertini, R., Vieira, A. T., Cunha, F. Q., Poole, S., Allegretti, M., Colotta, F., Teixeira, M. M. (2004) Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Br. J. Pharmacol. 143, 132-142.
87. Lin, M., Carlson, E., Diaconu, E., Pearlman, E. (2007) CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis. J. Leukoc. Biol. 81, 786-792.